Format
Sort by
Items per page

Send to

Choose Destination

Best matches for antipsychotic agents AND clozapine AND hyperlipidemia AND olanzapine:

Search results

Items: 1 to 20 of 50

1.

Is there an interrelationship between the effects of antipsychotics on psychopathology and on metabolism?

Chukhin E, Terevnikov V, Takala P, Hakko H, Putkonen H, Räsänen P, Stenberg JH, Eronen M, Joffe G.

Nord J Psychiatry. 2016;70(3):190-4. doi: 10.3109/08039488.2015.1074283. Epub 2015 Oct 8.

PMID:
26450657
2.

Acute Necrotizing Pancreatitis Following Olanzapine Treatment and 759C/T Polymorphism of HTR2C Gene: A Case Report.

Rizos E, Tournikioti K, Alevyzakis E, Peppa M, Papazaxos K, Zorbas G, Michopoulos I, Liappas I, Papageorgiou C, Douzenis A.

In Vivo. 2015 Sep-Oct;29(5):529-31.

PMID:
26359410
3.

Improvements in body composition, anthropometric measurements and lipid profile following discontinuation of clozapine.

Wysokiński A, Sobów T.

Nord J Psychiatry. 2016;70(2):156-60. doi: 10.3109/08039488.2015.1056225. Epub 2015 Jul 3.

PMID:
26140393
4.

Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants.

Himmerich H, Minkwitz J, Kirkby KC.

Endocr Metab Immune Disord Drug Targets. 2015;15(4):252-60. Review.

PMID:
26100432
5.

Atypical Antipsychotics and the Risk of Hyperlipidemia: A Sequence Symmetry Analysis.

Takeuchi Y, Kajiyama K, Ishiguro C, Uyama Y.

Drug Saf. 2015 Jul;38(7):641-50. doi: 10.1007/s40264-015-0298-4.

PMID:
26001933
6.

The incidence of dyslipidemia (hypertriglyceridemia and hypercholesterolemia) in patients treated with the new generation of antipsychotic drugs compared to conventional therapy.

Sadibašić B, Macić-Džanković A, Šabić A, Torlak B, Lastrić G, Ćustović A.

Med Glas (Zenica). 2014 Aug;11(2):350-5.

PMID:
25082252
7.
8.

Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells.

Bentsen H, Solberg DK, Refsum H, Bøhmer T.

Prostaglandins Leukot Essent Fatty Acids. 2012 Jul;87(1):35-41. doi: 10.1016/j.plefa.2012.05.005. Epub 2012 Jun 15.

PMID:
22705264
9.

Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis.

Cohen D, Bonnot O, Bodeau N, Consoli A, Laurent C.

J Clin Psychopharmacol. 2012 Jun;32(3):309-16. doi: 10.1097/JCP.0b013e3182549259. Review.

PMID:
22544019
10.

Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment.

Hong CJ, Chen TT, Bai YM, Liou YJ, Tsai SJ.

World J Biol Psychiatry. 2012 Jan;13(1):22-9. doi: 10.3109/15622975.2010.551543. Epub 2011 Mar 4.

PMID:
21375366
11.

Management of schizophrenia in children and adolescents: focus on pharmacotherapy.

Masi G, Liboni F.

Drugs. 2011 Jan 22;71(2):179-208. doi: 10.2165/11585350-000000000-00000. Review.

PMID:
21275445
12.

Off-label second generation antipsychotics for impulse regulation disorders: a review.

Scheltema Beduin A, de Haan L.

Psychopharmacol Bull. 2010;43(3):45-81. Review.

PMID:
21150846
13.

Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.

Carrizo E, Fernández V, Connell L, Sandia I, Prieto D, Mogollón J, Valbuena D, Fernández I, de Baptista EA, Baptista T.

Schizophr Res. 2009 Aug;113(1):19-26. doi: 10.1016/j.schres.2009.05.007. Epub 2009 Jun 9. Erratum in: Schizophr Res. 2009 Nov;115(1):96.

PMID:
19515536
14.

Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia.

Henderson DC, Fan X, Copeland PM, Sharma B, Borba CP, Forstbauer SI, Miley K, Boxill R, Freudenreich O, Cather C, Evins AE, Goff DC.

Hum Psychopharmacol. 2009 Apr;24(3):225-32. doi: 10.1002/hup.1012.

15.

Metabolic risks in older adults receiving second-generation antipsychotic medication.

Brooks JO 3rd, Chang HS, Krasnykh O.

Curr Psychiatry Rep. 2009 Feb;11(1):33-40. Review.

PMID:
19187706
16.

Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension study.

Kumra S, Kranzler H, Gerbino-Rosen G, Kester HM, DeThomas C, Cullen K, Regan J, Kane JM.

J Child Adolesc Psychopharmacol. 2008 Aug;18(4):307-16. doi: 10.1089/cap.2007.0089.

17.
18.

Atypical antipsychotics: new drugs, new challenges.

Mathews M, Muzina DJ.

Cleve Clin J Med. 2007 Aug;74(8):597-606. Review.

PMID:
17708131
20.

Early changes of plasma lipids during treatment with atypical antipsychotics.

Rettenbacher MA, Ebenbichler C, Hofer A, Kemmler G, Baumgartner S, Edlinger M, Hummer M, Lechleitner M, Fleischhacker WW.

Int Clin Psychopharmacol. 2006 Nov;21(6):369-72.

PMID:
17012984

Supplemental Content

Loading ...
Support Center